Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schuitemaker

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Science (New York, N.Y.)|June 4, 1993
Relation of phenotype evolution of HIV-1 to envelope V2 configurationM Groenink, R A Fouchier, S Broersen, et al.
AIDS (London, England)|July 24, 1998
Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivoA B van 't Wout, L J Ran, M Nijhuis, et al.
Journal of Virology|January 7, 1998
Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couplesH Blaak, A B van't Wout, M Brouwer, et al.
Vaccine|July 31, 1998
New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRHH B Oonk, J A Turkstra, W M Schaaper, et al.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
Journal of Virology|March 1, 1992
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populationH Schuitemaker, M Koot, N A Kootstra, et al.
AIDS (London, England)|March 14, 2000
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyM H Reijers, H M Weigel, A A Hart, et al.
Journal of Virology|October 1, 1992
Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domainM Groenink, A C Andeweg, R A Fouchier, et al.
The Journal of Clinical Investigation|November 1, 1994
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionA B van't Wout, N A Kootstra, G A Mulder-Kampinga, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Science (New York, N.Y.)|June 4, 1993
Relation of phenotype evolution of HIV-1 to envelope V2 configurationM Groenink, R A Fouchier, S Broersen, et al.
AIDS (London, England)|July 24, 1998
Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivoA B van 't Wout, L J Ran, M Nijhuis, et al.
Journal of Virology|January 7, 1998
Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couplesH Blaak, A B van't Wout, M Brouwer, et al.
Vaccine|July 31, 1998
New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRHH B Oonk, J A Turkstra, W M Schaaper, et al.
Journal of Virology|August 10, 1999
R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymusR D Berkowitz, A B van't Wout, N A Kootstra, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
Journal of Virology|March 1, 1992
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populationH Schuitemaker, M Koot, N A Kootstra, et al.
AIDS (London, England)|March 14, 2000
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyM H Reijers, H M Weigel, A A Hart, et al.
Journal of Virology|October 1, 1992
Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domainM Groenink, A C Andeweg, R A Fouchier, et al.
The Journal of Clinical Investigation|November 1, 1994
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionA B van't Wout, N A Kootstra, G A Mulder-Kampinga, et al.
Pageof 10